Infinity Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 18 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-10-06: Reporting owner Lynch Thomas J. Jr.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-06-17: Reporting owner LANDER ERIC S; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-06-17: Reporting owner EVNIN ANTHONY B; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-06-17: Reporting owner EVNIN ANTHONY B; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-10-06 | Lynch Thomas J. Jr. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $6.24 exercise price | 2009-10-08 | |
| 2009-06-17 | LANDER ERIC S Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,750 3,750 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | TANANBAUM JAMES B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | Babler Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | Babler Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,875 1,875 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | Moss Franklin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | LEVINE ARNOLD J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | Lee Patrick Pak-Tin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-06-17 | HIXSON HARRY F JR Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,625 5,625 owned after | $5.63 exercise price | 2009-06-19 | |
| 2009-01-05 | ADAMS JULIAN Officer (President of R&D and CSO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $7.27 exercise price | 2009-01-07 | |
| 2009-01-05 | Perkins Adelene Q Officer (Pres & Chief Business Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $7.27 exercise price | 2009-01-07 | |
| 2009-01-05 | Holtzman Steven H Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $7.27 exercise price | 2009-01-07 |